🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective is to determine whether immune responses to Tdap (GlaxoS...
Status
Completed
Location
Birmingham Pediatrics, 806 Saint Vincent's Drive, Suite 615
Start Date
2011-09
Trial ID
NCT01424644
Pre-licensure studies of GSK Biologicals' Boostrix® have shown it to be gen...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-03
Trial ID
NCT00297856
Treatments Being Tested
Objectives: To provide safety data on revaccination with ADACEL® vaccine. ...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00347958
Treatments Being Tested
The aim of the study is to assess the immunogenicity and safety profile of ...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01993173
Primary Objectives : * To describe the long-term humoral immune responses ...
Status
Completed
Location
Investigational Site Number : 7100001
Start Date
2021-01-27
Trial ID
NCT04300192
The aim of this study is to describe immunogenicity of a single booster dos...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01629589
This study is designed to assess the immunogenicity and safety of tetanus t...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01689324
Treatments Being Tested
This study will assess the immunogenicity and reactogenicity of the candida...
Status
Completed
Location
Multiple Locations
Start Date
2002-01
Trial ID
NCT01277705
New immunization recommendations in the US include vaccination of adolescen...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-01-25
Trial ID
NCT00282295
The aim of the study is to assess safety and immunogenicity of a single dos...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01642589